Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Return on Equity (2020 - 2025)

Historic Return on Equity for BioScience Health Innovations (BHIC) over the last 6 years, with Q3 2025 value amounting to 0.52%.

  • BioScience Health Innovations' Return on Equity rose 3800.0% to 0.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52%, marking a year-over-year increase of 3800.0%. This contributed to the annual value of 0.21% for FY2024, which is 208000.0% down from last year.
  • As of Q3 2025, BioScience Health Innovations' Return on Equity stood at 0.52%, which was up 3800.0% from 0.64% recorded in Q2 2025.
  • Over the past 5 years, BioScience Health Innovations' Return on Equity peaked at 10.6% during Q3 2023, and registered a low of 273.07% during Q4 2023.
  • Over the past 5 years, BioScience Health Innovations' median Return on Equity value was 0.14% (recorded in 2024), while the average stood at 15.55%.
  • Within the past 5 years, the most significant YoY rise in BioScience Health Innovations' Return on Equity was 2732200bps (2024), while the steepest drop was -104700bps (2024).
  • BioScience Health Innovations' Return on Equity (Quarter) stood at 1.13% in 2021, then plummeted by -335bps to 4.92% in 2022, then plummeted by -5453bps to 273.07% in 2023, then skyrocketed by 100bps to 0.14% in 2024, then skyrocketed by 258bps to 0.52% in 2025.
  • Its Return on Equity stands at 0.52% for Q3 2025, versus 0.64% for Q2 2025 and 0.54% for Q1 2025.